Clinical and molecular characteristics of pulmonary sarcomatoid carcinoma
Jae Kyeom Sim, Sang Mi Chung, Jong Hyun Choi, Jee Youn Oh, Seung Heon Lee, Je Hyeong Kim, Kyung Hoon Min, Gyu Young Hur, Jae Jeong Shim, Kyung Ho Kang, Bong Kyung Shin, Ju Han Lee, Sung Yong Lee
Korean J Intern Med. 2018;33(4):737-744.   Published online 2018 Feb 20     DOI: https://doi.org/10.3904/kjim.2017.245
Citations to this article as recorded by Crossref logo
18F-FDG PET/CT imaging in pulmonary sarcomatoid carcinoma and correlation with clinical and genetic findings
Xiaodong Wu, Yan Huang, Yuan Li, Qiang Wang, Huoqiang Wang, Lei Jiang
Annals of Nuclear Medicine.2019; 33(9): 647.     CrossRef
A Histologically Complete Response to Immunotherapy Using Pembrolizumab in a Patient with Giant Cell Carcinoma of the Lung: An Additional Report and Literature Review
Tomoo Kakimoto, Mamoru Sasaki, Tatsuya Yamamoto, Arifumi Iwamaru, Kentaro Ogata, Ko Lee, Shingo Nakayama, Naoto Minematsu
Case Reports in Oncological Medicine.2019; 2019: 1.     CrossRef
Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinoma
Jiyun Lee, Hyun Ae Jung, Youjin Kim, Sangjoon Choi, Joungho Han, Yoon-La Choi, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park, Jong-Mu Sun
Lung Cancer.2018; 122: 160.     CrossRef